Precision Genomics Collaboratory News

Where most see microbes as an adversary to be destroyed posthaste, Claudia Gunsch has always seen potential.

The Sequencing and Genomic Technologies core facility has acquired a new sequencing platform.

Duke Health is building upon its longstanding history of innovative research by joining with nference to transform healthcare by making biomedical knowledge computable.

Charlie Gersbach has been elected Fellows of the National Academy of Inventors class of 2022.

A large study of military members led by researchers at Duke Health and the Durham VA identified four genes that are linked to an increased risk of suicidal thoughts and behaviors.

Testing for procalcitonin, a blood biomarker that is increased in people with a bacterial infection, could help physicians more quickly and effectively determine whether patients need antibiotics.

A team of Duke scientists studying how other animals regrow damaged tissues has made an important step toward controlling at least one part of the regenerative machinery with precision.

Aravind Asokan will lead a new strategic partnership with Danaher Corporation to form the first Danaher Beacon for Gene Therapy Innovation, a new initiative designed to access breakthrough science to create technologies and applications that will improve human health.

Your body is in constant dialogue with its own fat, and fat talks a lot.

A family history of cancer and genetic variants that might be inherited appear to be important risk factors for Black men diagnosed with early-onset prostate cancer